IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biohaven Pharmactl Hldg Co L (BHVN)

CUSIP: G11196105 | Healthcare · Biotechnology | Mid Cap | 641 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Knoll Capital Management, LLC2,352,520
16.3% of portfolio›$35.0M
StyleTurnoverLocationFiled
Knoll Capital Management, LLC
2,352,520$35.0M16.3%CoreMediumMiami, FL2026-09-10